Hospital-Insurer Relations and Competition Law in the Malaysian Private Healthcare Sector

Rising medical costs have become a global healthcare concern and Malaysian private healthcare sector is not immune from this challenge. One area of concern is the relationship between providers and payers in the private healthcare sector. Rising healthcare costs have intensified commercial tensions over reimbursement discounts, provider-panel access and management of insured patients. The recent report of the Malaysian Parliament’s Public Accounts Committee recorded concerns that hospitals may face demands for substantial discounts and possible removal from provider panels when those demands are not accepted. At the same time, stakeholders remain uncertain whether collective dispute-resolution and cost-control measures comply with the Competition Act 2010. This article examines how the Competition Act 2010 applies to provider-payer arrangements in Malaysian private healthcare sector. The article combines doctrinal legal research and regulatory gap analysis with documentary evidence from Malaysia and a focused comparative analysis of the Netherlands, Australia and the United Kingdom. Three main findings emerge. The analysis shows that genuine bilateral negotiations and selective contracting are not inherently anti-competitive and may help control healthcare costs. However, closer scrutiny is required where a dominant payer imposes exclusionary or discriminatory terms. In relation to collective agreements, coordination among competing hospitals or insurers may infringe competition law especially where it concerns future prices, common discount levels or shared trading conditions. Apart from that, the allegation of payer pressure requires a proper assessment of market definition, dominance, competitive harm and objective justifications. The analysis also finds that Malaysia lacks a healthcare-specific framework for supervised information exchange and competition-compliant dispute resolution. Accordingly, the article proposes a framework based on a MyCC market review, sector-specific guideline, objective panel and top rules and independent data governance.

competition law, private healthcare, hospital-insurer bargaining, de-empanelment, buyer power

1. ACCC. (2022). Small business collective bargaining guidelines (Issue December). Australian Competition & Consumer Commission. www.accc.gov.au [Google Scholar] [Crossref]

2. ACCC. (2025). Determination: Application for revocation of A91400 and the substitution of authorisation AA1000677 lodged by Catholic Health Australia Limited. ACCC (or Australian Competition and Consumer Commission). [Google Scholar] [Crossref]

3. Ahamat, H., & Rahman, N. A. (2017). State-owned enterprises, market competition and the boundaries of competition law in Malaysia. Jurnal Pengurusan, 51, 173–181. https://doi.org/10.17576/pengurusan-2018-51-15 [Google Scholar] [Crossref]

4. Ahamat, H., Rahman, N. A., & Al Anshori, M. R. (2020). Monopsony, powerful buyers and small sellers: Analysis of Malaysian competition law and lessons learnt from Indonesia. International Journal of Globalisation and Small Business, 11(3), 241–257. https://doi.org/10.1504/IJGSB.2020.109548 [Google Scholar] [Crossref]

5. Arrow, K. J. (1963). Uncertainty and the welfare economics of medical care. American Economic Review, 53(5), 941–973. [Google Scholar] [Crossref]

6. Arvinder-Singh, H. S., & Harbaksh-Singh, M. S. (2022). The opinion of general practitioners in Malaysia on newly imposed third party health administrator policies in primary care. Medical Journal of Malaysia, 77(3), 306–312. [Google Scholar] [Crossref]

7. Authority for Consumers & Market. (2023a). ACM: Trade associations cannot influence individual contract negotiations in the health-care sector. https://www.acm.nl/en/publications/acm-trade-associations-cannot-influence-individual-contract-negotiations-health-care-sector#:~:text=14-7-2023 Draft version of ACM’s,and health-care contracting (in Dutch)&text=20-12-2022 ACM has launched investigations,to influence individual health-care contracts [Google Scholar] [Crossref]

8. Authority for Consumers & Market. (2023b). Brancheorganisaties en zorgcontractering [Guideline on Trade Associations and Healthcare Contracting]. [Google Scholar] [Crossref]

9. Bates, L. J., & Santerre, R. E. (2008). Do health insurers possess monopsony power in the hospital services industry? International Journal of Health Care Finance and Economics, 8(1), 1–11. https://doi.org/10.1007/s10754-007-9026-7 [Google Scholar] [Crossref]

10. Bes, R. E., Curfs, E. C., Groenewegen, P. P., & de Jong, J. D. (2017). Selective contracting and channelling patients to preferred providers: A scoping review. Health Policy, 121(5), 504–514. https://doi.org/10.1016/j.healthpol.2017.03.008 [Google Scholar] [Crossref]

11. BNM. (2026). White Paper on White Paper on Base MHIT Plan. [Google Scholar] [Crossref]

12. Boone, J., & Schottmuller, C. (2019). Do health insurers contract the best providers? Provider networks, quality, and costs. International Economic Review, 60(3). [Google Scholar] [Crossref]

13. CMA. (2014a). Private healthcare market investigation : Final report (Issue April). [Google Scholar] [Crossref]

14. CMA. (2014b). Private Healthcare Market Investigation Order. Competition & Market Authority. https://assets.publishing.service.gov.uk/media/542c1543e5274a1314000c56/Non-Divestment_Order_amended.pdf [Google Scholar] [Crossref]

15. Cutler, D. M., McClellan, M., & Newhouse, J. P. (2000). How Does Managed Care Do It? The RAND Journal of Economics, 31(3), 526. https://doi.org/10.2307/2600999 [Google Scholar] [Crossref]

16. Dafny, L., Duggan, M., & Ramanarayanan, S. (2012). Paying a premium on your premium? Consolidation in the US health insurance industry. American Economic Review, 102(2), 1161–1185. https://doi.org/10.1257/aer.102.2.1161 [Google Scholar] [Crossref]

17. Douven, R., Burger, M., & Schut, F. (2020). Does managed competition constrain hospitals’ contract prices? Evidence from the Netherlands. Health Economics, Policy and Law, 15(3), 341–354. https://doi.org/10.1017/S1744133119000215 [Google Scholar] [Crossref]

18. Gaynor, M., Ho, K., & Town, R. J. (2015). The industrial organization of health-care markets. Journal of Economic Literature, 53(2), 235–284. https://doi.org/10.1257/jel.53.2.235 [Google Scholar] [Crossref]

19. Gaynor, M., & Starc, A. (2026). Competition in health insurance markets. In Journal of Economic Perspectives (Vol. 40, Issue 2). [Google Scholar] [Crossref]

20. Gowrisankaran, G., Nevo, A., & Town, R. (2015). Mergers when prices are negotiated: Evidence from the hospital industry. American Economic Review, 105(1), 172–203. https://doi.org/10.1257/aer.20130223 [Google Scholar] [Crossref]

21. Gudiksen, K. L., Montague, A. D., King, J. S., Gu, A. Y., Fulton, B. D., & Greaney, T. L. (2020). Preventing Anticompetitive Contracting Practices in Healthcare Markets (Issue September). sourceonhealthcare.org [Google Scholar] [Crossref]

22. Guy, M. (2019). Between ‘ going private ’ and ‘ NHS privatisation ’ : patient choice , competition reforms and the relationship between the NHS and private healthcare in England. Legal Studies, 39(3), 479–498. [Google Scholar] [Crossref]

23. Hardy, T., & McCrystal, S. (2020). Bargaining in a Vacuum? An Examination of the Proposed Class Exemption for Collective Bargaining for Small Businesses. Sydney Law Review, 42(3), 311–342. [Google Scholar] [Crossref]

24. Ho, K. (2009). Insurer-Provider Networks in the Medical Care Market. American Economic Review, 99(1), 393–430. [Google Scholar] [Crossref]

25. Ho, K., & Lee, R. S. (2017). Insurer competition in health care market. Econometrica, 85(2), 379. [Google Scholar] [Crossref]

26. Ho, K., & Lee, R. S. (2019). Equilibrium Provider Networks: Bargaining and Exclusion in Health Care Markets. American Economic Review, 109(2), 473–522. [Google Scholar] [Crossref]

27. Hutchinson, T., & Duncan, N. (2012). Defining and describing what we do: doctrinal legal research. Deakin Law Review, 17(1), 83–119. [Google Scholar] [Crossref]

28. King, S. P. (2013). Collective Bargaining by Business: Economic and Legal Implications. UNSW Law Journal, 36(1), 107–139. [Google Scholar] [Crossref]

29. Moriya, A. S., Vogt, W. B., & Gaynor, M. (2010). Hospital prices and market structure in the hospital and insurance industries. Health Economics, Policy and Law, 5(4), 459–479. https://doi.org/10.1017/S1744133110000083 [Google Scholar] [Crossref]

30. MyCC. (2012b). Guidelines on Abuse of Dominant Position. MyCC. http://www.mycc.gov.my/sites/default/files/handbook/MYCC 4 Guidelines Booklet BOOK2-6 FA copy.pdf [Google Scholar] [Crossref]

31. MyCC. (2012a). Guidelines on chapter 1 prohibition anti-competitive agreement. [Google Scholar] [Crossref]

32. MyCC. (2025). MyCC warns private healthcare providers against price fixing. MyCC. [Google Scholar] [Crossref]

33. Noriza, R., Ariffin, R., Rosnah, N., & Abdullah, W. (2018). The Implications of Legislative Controls on Private Hospitals in Malaysia. Institutions and Economies, 10(2), 62–94. [Google Scholar] [Crossref]

34. Onn, L. P. (2015). What Lies Ahead for Malaysian Healthcare ? (2015–4). [Google Scholar] [Crossref]

35. Parliament of Malaysia. (2026). Penyata jawatankuasa kira-kira wang negara (PAC) : Peningkatan bayaran insurans kesihatan, caj hospital swasta dan impak kepada kesihatan awam (DR.12 /2026). [Google Scholar] [Crossref]

36. Porrini, D. (2004). Information Exchange as Collusive Behaviour : Evidence from an Antitrust Intervention in the Italian Insurance Market. The Geneva Papers on Risk and Insurance, 29(2), 219–233. [Google Scholar] [Crossref]

37. Rahman, N. A., Faudzi, M. H. M., Ahamat, H., & Ghadas, Z. A. A. (2016). Competition Law and the Malaysian Financial Services Market : An Analysis of the Structure and Level of Competition in the Market. International Journal of Economics and Finance, 9(4). [Google Scholar] [Crossref]

38. Rahman, N. A., Safri, R. A., & Tupari, M. A. (2025). Recent developments of competition law in Malaysia: Legal challenges and analysis of decisions. INSAF| The Journal of the Malaysian Bar, 42(1). [Google Scholar] [Crossref]

39. Ramaiah, A. K. (2015). Competition Law and Exemption Policy in Malaysia: When, Why and Why Not? International Journal of Business, Economics and Law, 8(4), 80–87. [Google Scholar] [Crossref]

40. Rosnah, N., Abdullah, W., & Kwee-heng, L. (2011). Impact of The Private Healthcare Facilities And Services Act 1998 (Act 586) &Regulations 2006 on The Medical Practice in Corporate Private Hospitals In Malaysia. OIDA International Journal of Sustainable Development, 2(9), 89–106. [Google Scholar] [Crossref]

41. Schut, F. T., & Varkevisser, M. (2017). Competition policy for health care provision in the Netherlands. Health Policy, 121(2), 126–133. https://doi.org/10.1016/j.healthpol.2016.11.002 [Google Scholar] [Crossref]

42. Sinaiko, A. D. (2026). Anticompetitive Contracts Between Insurers and Providers in Health Care. Journal of Economic Perspectives, 40(2), 69–92. [Google Scholar] [Crossref]

43. Sorensen, A. T. (2003). Insurer-hospital bargaining: Negotiated discounts in post-deregulation connecticut. Journal of Industrial Economics, 51(4), 469–490. https://doi.org/10.1111/j.0022-1821.2003.00211.x [Google Scholar] [Crossref]

44. Stolper, K. C. F., Boonen, L. H. H. M., Schut, F. T., & Varkevisser, M. (2019). Managed competition in the Netherlands: Do insurers have incentives to steer on quality? Health Policy, 123(3), 293–299. https://doi.org/10.1016/j.healthpol.2018.08.018 [Google Scholar] [Crossref]

45. Theil, S. (2025). Carefully Tailored: Doctrinal Methods and Empirical Contributions. Oxford Journal of Legal Studies, 45(4), 1047–1075. https://doi.org/10.1093/ojls/gqaf029 [Google Scholar] [Crossref]

46. Town, R., & Vistnes, G. (2001). Hospital competition in HMO networks. Journal of Health Economics, 20(5), 733–753. [Google Scholar] [Crossref]

47. van den Broek-Altenburg, E. M., & Atherly, A. J. (2020). The relation between selective contracting and healthcare expenditures in private health insurance plans in the United States. Health Policy, 124(2), 174–182. https://doi.org/10.1016/j.healthpol.2019.12.008 [Google Scholar] [Crossref]

48. Victoor, A., Brabers, A. E. M., van Esch, T. E. M., & De Jong, J. D. (2019). An assessment of the Dutch experience with health insurers acting as healthcare advisors. PLoS ONE, 14(11), 1–13. https://doi.org/10.1371/journal.pone.0224829 [Google Scholar] [Crossref]

49. Yaqin, A. (2007). Legal research and writing. Lexis Nexis. [Google Scholar] [Crossref]

50. Zou, K., Li, H. Y., Zhou, D., & Liao, Z. J. (2020). The effects of diagnosis-related groups payment on hospital healthcare in China: A systematic review. BMC Health Services Research, 20(1), 1–11. https://doi.org/10.1186/s12913-020-4957-5 [Google Scholar] [Crossref]

• Conflict of Law in the Safeguarding of Malaysian Intangible Cultural Heritage: A Way Forward
• Alternative Dispute Resolution in India: A Brief Overview Justice Delayed is Justice Denied. - William E. Gladstone
• The Role of Museums in Safeguarding Cultural Heritage Rights: Balancing Access and Repatriation
• An Evaluation of the Universal Declaration of Human Rights' Significance and Application in Nigeria
• The Role of International Law in Shaping National Immigration Policies.